PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756
- PMID: 7989969
PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756
Abstract
PET studies were carried out on brain dopamine D1 receptors using two new ligands, [11C]SCH 39166 and [11C]NNC 756.
Methods: Four normal subjects and eight predominantly unilateral patients with early Parkinson's disease were investigated. Each of them underwent both a PET scan with [11C]SCH 39166 and one with [11C]NNC 756. A dose of about 185 MBq (5 mCi) of these ligands was administered intravenously and a dynamic PET scan with an ECAT 931/08 PET camera was carried out. Ratios between the striatal and cerebellar uptake of these compounds were calculated.
Results: Both [11C]SCH 39166 and [11C]NNC 756 accumulated in the striatum. There was also some neocortical binding; 75% of the striatal value in the case of [11C]SCH 39166 and 60% with [11C]NNC 756 which displayed higher (p < 0.01) uptake in the striatum than [11C]SCH 39166. There were no significant side-to-side differences in the controls nor in the parkinsonian patients.
Conclusions: These results imply that both [11C]SCH 39166 and [11C]NNC 756 can be used in PET studies for the visualization and quantification of dopamine D1 receptors. Since [11C]NNC 756 has a significantly better signal-to-noise ratio in the striatum than [11C]SCH 39166, it seems to offer definite advantages for studies of D1 receptors.
Similar articles
-
Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.J Nucl Med. 1998 Dec;39(12):2061-8. J Nucl Med. 1998. PMID: 9867142
-
PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.Synapse. 1999 May;32(2):93-109. doi: 10.1002/(SICI)1098-2396(199905)32:2<93::AID-SYN3>3.0.CO;2-C. Synapse. 1999. PMID: 10231129
-
PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.Psychopharmacology (Berl). 1993;113(2):149-56. doi: 10.1007/BF02245691. Psychopharmacology (Berl). 1993. PMID: 7855175 Clinical Trial.
-
[Muscarinic cholinergic receptor imaging of parkinsonian brain using 11C-NMPB and PET].Nihon Rinsho. 1997 Jan;55(1):233-7. Nihon Rinsho. 1997. PMID: 9014456 Review. Japanese.
-
(+)-8-Chloro-5-(7-benzofuranyl)-7-hydroxy-3-[11C]methyl-2,3,4,5-tetrahydro-1H-3-benzazepine.2006 Mar 17 [updated 2008 Jan 12]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2006 Mar 17 [updated 2008 Jan 12]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641216 Free Books & Documents. Review.
Cited by
-
Dopamine, Immunity, and Disease.Pharmacol Rev. 2023 Jan;75(1):62-158. doi: 10.1124/pharmrev.122.000618. Epub 2022 Dec 8. Pharmacol Rev. 2023. PMID: 36757901 Free PMC article. Review.
-
[Nuclear medicine imaging in patients with Parkinson's syndrome: an update].Nervenarzt. 2010 Oct;81(10):1160-7. doi: 10.1007/s00115-010-3026-4. Nervenarzt. 2010. PMID: 20844855 Review. German.
-
Probing cortical dopamine function in schizophrenia: what can D1 receptors tell us?World Psychiatry. 2003 Oct;2(3):166-71. World Psychiatry. 2003. PMID: 16946930 Free PMC article.
-
In vivo DA D(1) receptor selectivity of NNC 112 and SCH 23390.Mol Imaging Biol. 2007 May-Jun;9(3):117-25. doi: 10.1007/s11307-007-0077-4. Mol Imaging Biol. 2007. PMID: 17473957
-
Dopamine receptor mapping with PET imaging in Parkinson's disease.J Neurol. 2014 Dec;261(12):2251-63. doi: 10.1007/s00415-014-7302-2. Epub 2014 Mar 15. J Neurol. 2014. PMID: 24627109 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous